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Purpose. To evaluate the feasibility of wide-field Megahertz (MHz) OCT imaging in patients with diabetic retinopathy.Methods. A
consecutive series of 15 eyes of 15 patients with diagnosed diabetic retinopathy were included. All patients underwent Megahertz
OCT imaging, a close clinical examination, slit lamp biomicroscopy, and funduscopic evaluation. To acquire densely sampled, wide-
field volumetric datasets, an ophthalmic 1050 nm OCT prototype system based on a Fourier-domain mode-locked (FDML) laser
source with 1.68MHz A-scan rate was employed. Results. We were able to obtain OCT volume scans from all included 15 patients.
Acquisition time was 1.8 seconds. Obtained volume datasets consisted of 2088 × 1044 A-scans of 60∘ of view.Thus, reconstructed en
face images had a resolution of 34.8 pixels per degree in x-axis and 17.4 pixels per degree. Due to the densely sampled OCT volume
dataset, postprocessed customized cross-sectional B-frames through pathologic changes such as an individual microaneurysm or a
retinal neovascularization could be imaged. Conclusions. Wide-field Megahertz OCT is feasible to successfully image patients with
diabetic retinopathy at high scanning rates and a wide angle of view, providing information in all three axes. The Megahertz OCT
is a useful tool to screen diabetic patients for diabetic retinopathy.
1. Introduction
Diabetic retinopathy is a leading cause for blindness in indus-
trialized countries [1].The prevalence of diabetes and diabetic
retinopathy is increasing worldwide including first world
countries [2]. Thus, early detection of diabetic changes of the
posterior ocular fundus for an individualized and optimized
treatment is of high importance.
Multiple noninvasive diagnostic imaging tools for screen-
ing as well as detection and monitoring of the diabetic reti-
nopathy are available, for example, fundus cameras [3, 4] or
scanning laser ophthalmoscopy [5] for en face images of the
posterior fundus or OCT scans for cross-sectional images of
the central retina [6–8].
In general, retinal diseases such as diabetic retinopathy
can manifest in the central as well as peripheral retina and
can initially develop subtle pathologic alterations. The NHS
Diabetic Eye Screening Program in the United Kingdom as
well as the conclusions of Early Treatment Diabetic Reti-
nopathy Study, for example, demands a field of view of 45∘ ×
40∘ for fundus cameras to ensure high sensitivity and spec-
ificity to successfully screen for diabetic retinopathy. There-
fore, the requirements for valid images to effectively depict
the posterior fundus are a wide angle of view and a high
resolution. Fundus cameras fulfilling those requirements are
able to obtain en face images in 𝑥-𝑦-axis with useful infor-
mation depicting potential diabetic pathologies located on
the surface of the retina. On the other hand, commercially
available OCT devices have been able to obtain cross-
sectional scans of the central retina but were limited to a nar-
row angle of view (30 × 20∘) and slow acquisition speed,
Hindawi Publishing Corporation
Journal of Diabetes Research
Volume 2015, Article ID 305084, 5 pages
http://dx.doi.org/10.1155/2015/305084
2 Journal of Diabetes Research
thus failing to provide enough pixels per degree in recon-
structed en face display modes.
The recently introduced ultrahigh-speed swept source
Fourier-domainmode-locked (FDML)OCT [9–11] is feasible
at high scanning rates providing images with a wide angle
of view. The obtained volume scans of the retina allowed a
reconstruction of high resolution en face images as well as
histology-like cross-sectional retinal scans (B-frames) depict-
ing the fundus beyond the centralmacular area with an image
quality comparable to current established OCT devices [9].
The purpose of this study was to evaluate the feasibility
of this novel device imaging diabetic patients with diagnosed
diabetic retinopathy.
2. Patients and Methods
We retrospectively selected 15 eyes of 15 consecutive patients
with diagnosed diabetic retinopathy (5 eyes with proliferative
diabetic retinopathy versus 10 eyes with nonproliferative
diabetic retinopathy) who were imaged between October
2013 and April 2014 in the MHz OCT study at the LMU
Eye Hospital Munich (German Clinical Trial Register ID
DRKS00005173). Three were females and 12 were males.
Mean age was 57.4 ± 11.1 years (range 41–81 years). Ethics
committee approval was obtained in June 2013. Written
informed consent was obtained from all patients prior to
OCT imaging. The research adhered to the tenets of the
Declaration of Helsinki.
All patients underwent Megahertz OCT imaging, a close
clinical examination including measurements of refraction,
best corrected VA, slit lamp biomicroscopy, and funduscopic
evaluation. Patients were not dilated specifically for the
imaging procedures. Only one eye per subject was selected
to avoid any intraindividual correlations.
The ophthalmic OCT prototype system is based on a
Fourier-domain mode-locked (FDML) laser source, which
makes the acquisition of densely sampled, wide-field volu-
metric datasets possible. Details of this custom FDML MHz
OCT system can be found in [9, 12, 13].
In summary, the system employs a rapidly wavelength-
tunable FDML laser with a center wavelength of 1050 nm for
higher tissue penetration in contrast to spectral-domain
OCT. It can obtain an ultrahigh number of 1.68 Mio depth
scans (A-scans) per second.The sweep bandwidth of approx-
imately 70 nm makes an axial resolution of 10 𝜇m in tissue
possible. 1.6mW sample arm power is incident on the eye,
which is below the limits declared in the American National
Standard Institute (ANSI) standards for safe ocular exposure
(ANSI, “Safe Use of Lasers & Safe Use of Optical Fiber Com-
munications,” American National Standard Institute, Z136
Committee). At this power, the device achieves a sensitivity
of 91 dB.
3. Results
We were able to obtain OCT volume scans from all
included 15 patients. Acquisition time was 1.8 seconds. Two-
dimensional en face images were reconstructed by taking
the average of each A-scan of the three-dimensional OCT
Figure 1: Reconstructed en face wide-field fundus images of all 15
patients; artifacts are shown in detail in Figure 2.
imaging data to provide a first overview. Then, arbitrary
cross-sectional views can be obtained at every location for
a closer examination as shown later on. Wide-field en face
images from all patients can be seen in Figure 1.
Artifacts and possible quality modulations were pupillary
or ciliary shadowing as known from other wide-field devices;
motion artifacts such as eye blinks result in horizontal black
stripes while saccades result in a “misalignment phenome-
non” of the reconstructed en face images; see Figure 2. Ciliary
shadowing is the only observed artifact that can be solved
with pupil dilation.
Angle of view of the OCT imaging data was 60∘ in
diameter including the macular area, optic disc, and midpe-
ripheral retina significantly beyond the major vessel arcades;
see Figure 3. For example, the NHS Diabetic Eye Screening
Program in the United Kingdom demands a field of view of
45∘ × 40∘ for fundus cameras, which is also covered by the
three-dimensional data of the Megahertz OCT.
Obtained volume datasets consisted of 2088 × 1044 A-
scans with 60∘ field of view. Thus, reconstructed en face
images had a resolution of 34.8 pixels per degree in 𝑥-axis
and 17.4 pixels per degree in 𝑦-axis revealing fine details
such as retinal microaneurysms (see Figures 4(a) and 4(c)).
Figure 4(e) shows a cross-sectional scan of the imaged retina
through a microaneurysm providing information in 𝑧-axis.
Figures 4(b) and 4(d) display images of the same eye obtained
with a wide-field scanning laser ophthalmoscope (Optos plc,
Dunfermline, UK) serving as a reference.
Additionally, customized postprocessed B-frames depict
retinal or choroidal regions of interest in 𝑥-𝑦- and 𝑧-axis; see
Figure 5.
Pathologic changes such as an individual microaneurysm
or a retinal neovascularisation could be imaged in arbitrary
customized cross-sections extracted from to the densely
sampled OCT volume dataset.
4. Discussion
In this study, for the first time, we were able to obtain images
of the posterior fundus of patients with diabetic retinopathy
applying the recently [9] novel wide-field Megahertz OCT
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Figure 2: Artifacts of reconstructed en face wide-field fundus images with pupillary shadowing in (a) (∗) and ciliary shadowing in (b) (∗∗).
Eye blinks result in horizontal black stripes seen in (c) and saccades in misalignments (see (d)) in the reconstructed en face images.
(a) (b)
Figure 3: OCT images cover a field of view with a diameter of 60∘ which corresponds to 45∘ × 40∘ as shown in the en face reconstruction in
(a). Cross-sectional views (B-frames) can be obtained at every location as seen in (b).
device. Volume scans from all imaged patients allowed for
reconstructed high resolution en face images of the central
and midperipheral fundus as well as cross-sectional scans of
the retinal area of interest. A wide field of view is important
for diagnostic tools used for retinal diseases to depict alter-
ations located beyond the central posterior fundus, such as in
the presented case series of patients with diabetic retinopathy.
Given the acquisition speed of 1.68MHz (1.680.000 A-
scans per second), the obtained volume scans are densely
sampled, provide a sufficient angle of view of the central as
well as midperipheral fundus, and result in high resolution
images of each customized postprocessed arbitrary B-scan
extracted from the volume scan.
Commercially available noninvasive wide-field fundus
devices are able to successfully depict the posterior fundus
of patients with diabetic retinopathy in 𝑥-𝑦-axis [14] but
cannot provide any information in 𝑧-axis. This means that
devices imaging en face posterior fundus are not able to
depict potential pathologies that do not show at the surface
of the retina. The obtained MHz OCT volume scans of
the retina on the other side allow the reconstruction of en
face images which have been shown to exhibit comparable
image quality to commercially available wide-field fundus
devices [9] and have the additional significant advantage to
provide information of the depicted area with cross-sectional
scans also in 𝑧-axis. Cross-sectional images of patients
with diabetic retinopathy obtained with the MHz OCT are
therefore able to depict pathomorphologic alterations such
as microaneurysms, neovascularizations (Figures 4 and 5),
or intraretinal fluid and can identify their extension within
middle or outer retinal layers. This additional information
is missing in fundus photography due to the information
provided only in 𝑥-𝑦-axis.
The challenges with this new technology are the above
mentioned ciliary and papillary shadowing which is known
from other wide-field devices and motion artifacts (eye
blinks, saccades) due to an acquisition time of 1.8 seconds,
which in future could be reduced with faster beam scanners.
Given the known inverse relationship between acquisition
speed and obtained sensitivity, the achieved signal intensity
of the acquired images can be significantly improved by aver-
aging processes feasible at scanning rates beyond 1.000.000
A-scans per second and by applying higher optical power.
Limitations of our pilot study were the small number of
15 patients which was also limited by our ethics committee
because of the pilot character of our study design. Further
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Figure 4: Reconstructed MHz OCT en face wide-field fundus image of left eye (a) with detail (c) versus wide-field scanning laser
ophthalmoscopy (SLO) image (b) with detail (d). Cross-sectional MHz OCT scan from the same dataset (a, c) through a microaneurysm
(red arrow) providing information in 𝑧-axis (e).
studies with large number of patients will have to confirm the
feasibility. A further development of the presentedMHzOCT
device on the other hand will facilitate a higher competition
with other diagnostic tools such as fundus cameras for
screening purposes which require diagnostic tools that are
easy to handle and inexpensive and create data volumes that
can be transferred easily within an established network.
In summary, wewere able to demonstrate the feasibility of
the wide-field Megahertz OCT to successfully image patients
with diabetic retinopathy at high scanning rates and a wide
angle of view, providing information in all three axes. The
Megahertz OCT is a useful tool to screen diabetic patients
for diabetic retinopathy.
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Figure 5: Reconstructed MHz OCT en face wide-field fundus image of right eye (a) with neovascularisations (green arrows); star shows
blinking as horizontal black stripe; line represents cross-sectional scan of (b). (b) shows B-frame obtained in postprocessing through the
neovascularisations seen in (a), with green arrows pointing at neovascularisations. The two horizontal lines are an artifact from the image
processing.
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